Pronota logo — Pioneering early detection diagnostics to improve patient ca...

Pronota

Pioneering early detection diagnostics to improve patient care for critical health conditions.

Founded 2004 Series C Total: $39.31M Biotechnology, Health Care

General Information

Company Name Pronota
Founded Year 2004
Industries Biotechnology, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Pronota. To contact Pronota, visit pronota.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pronota compare?

A PDF of Pronota and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pronota soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pronota

Pronota, with its slogan "Pioneering early detection diagnostics to improve patient care for critical health conditions," specializes in developing and commercializing innovative diagnostics for the early detection of critical health conditions such as heart failure, pre-eclampsia, and sepsis. The company's non-invasive, validated diagnostics are proprietary and aimed at enhancing patient care. With robust support from investors like GIMV, LSP, KBC Private Equity, and JJDC, alongside a network of prominent key opinion leaders, Pronota is dedicated to advancing diagnosis and personalized healthcare. Initially known as Peakadilly NV, the company rebranded to Pronota NV in November 2006. Founded in 2004, the company is headquartered in Zwijnaarde, Belgium. The latest investment was a €1.40M Series C investment on 12 December 2012, marking a significant milestone in its growth and development. With a focus on biotechnology and healthcare, Pronota is poised to make a lasting impact in the early detection diagnostics space.

Business keywords: diagnostics, early detection, cardiology, investors, personalized healthcare, non-invasive, critical health conditions, innovation, quality of care, startups, Belgium, investments

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series C €1.40M -
12 Dec 2012
Series C €3.70M 7
Life Science Partners, GIMV +5
20 Jan 2012
Series B €1.50M 3
MP Healthcare Venture Management, MedSciences Capital +1
19 May 2010
Series B $1.95M -
30 Oct 2009
Series B $7.36M -
29 Jun 2009
Grant $2.80M -
10 Jul 2007
Grant $2.20M -
09 Oct 2006
Series A $10.60M -
22 Aug 2006
Series A $7.80M -
19 Apr 2006

Pronota Alternatives & Competitors

View All Alternatives
Pronota vs

Focused on early detection of liver disease

Post-IPO Equity
25 employees
Biotechnology, Health Care
Pronota vs
Endometrics
Endometrics United States

Time to end the silence

Pre-Seed
2 employees
Biotechnology, Health Care
Pronota vs

Pioneering non-invasive skin cancer detection with advanced infrared laser and AI technology

Venture round
11-50 employees
Biotechnology, Health Care

FAQ About Pronota

Pioneering early detection diagnostics to improve patient care for critical health conditions.
Pronota was founded in 2004.
Pronota operates in Biotechnology and Health Care. Its work centres on diagnostics, early detection, cardiology and investors.
Pronota has completed 9 funding rounds, raising a total of $39.31M. The latest funding stage is Series C.
Top alternatives and competitors to Pronota include ENDRA Life Sciences (Nasdaq: NDRA), Endometrics, Magnosco, Prenetics, Heartflow. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pronota and ENDRA Life Sciences (Nasdaq: NDRA) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pronota, https://bouncewatch.com/company/pronota, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes